Unlock instant, AI-driven research and patent intelligence for your innovation.

siRNA (small interfering RNA) of CDT1 gene of silent person, recombinant vector and application or siRNA and recombinant vector

A recombinant vector, silencing technology for molecular biology and biopharmaceutical applications

Active Publication Date: 2015-07-01
CHINA INST FOR RADIATION PROTECTION
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

CDT1 may also be related to the formation of cancer, which is highly expressed in a variety of cancer cells, and the relationship between this gene and cancer needs further study

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • siRNA (small interfering RNA) of CDT1 gene of silent person, recombinant vector and application or siRNA and recombinant vector
  • siRNA (small interfering RNA) of CDT1 gene of silent person, recombinant vector and application or siRNA and recombinant vector
  • siRNA (small interfering RNA) of CDT1 gene of silent person, recombinant vector and application or siRNA and recombinant vector

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] This example is used to illustrate the construction method of siRNA for silencing human CDT1 gene provided by the present invention.

[0018] According to the nucleotide sequence of the CDT1 gene reported in Genbank, three siRNA target sequences that inhibit the expression of the CDT1 gene were designed with reference to the siRNA design principles, respectively SEQ ID NO: 1-3, and a random control sequence SEQ ID NO.4 was designed at the same time ,As follows:

[0019] SEQ ID NO. 1: GGACACCATCTCTGAGCTT;

[0020] SEQ ID NO.2: GGAGGTCAGATTACCAGCT;

[0021] SEQ ID NO. 3: CCTACGTCAAGCTGGACAA;

[0022] SEQ ID NO. 4: TTCTCCGAACGTGTCACGT.

[0023] According to Blast gene homology analysis, the sequence of SEQ ID NO: 1-3 is not homologous to any human non-CDT1 gene sequence, so as to ensure the specificity of gene suppression.

[0024] For the above target sequences, refer to the siRNA design strategy, and design four pairs of shRNA (short hairpin RNA, shRNA) expression fr...

Embodiment 2

[0048]This example is used to illustrate the construction method of the siRNA recombinant vector for silencing human CDT1 gene provided by the present invention.

[0049] The vector used was the lentiviral vector pGC-LV (purchased from Shanghai Jikai Gene Chemical Technology Co., Ltd.). Its frame structure is:

[0050] hU6-MCS-Ubiquitin-EGFP-IRES-puromycin.

[0051] The construction method of the recombinant vector is as follows:

[0052] The sense and antisense strands of the 4 pairs of shRNA expression framework DNA sequences SEQ ID NO.1'-4' of the siRNA in Example 1 were respectively placed in annealing buffer (10mM Tris-HCl, 1mM EDTA, 0.1mM NaCl) at 90°C Water bath for 15 minutes, then naturally cool to room temperature, react to synthesize double-stranded DNA (dsDNA) sequence, digest the double-stranded DNA sequence with EcoRI and AgeⅠ, and use EcoRI and AgeⅠ to digest the lentiviral vector pGC-LV at the same time to produce dsDNA. Using T4 DNA ligase to ligate the dou...

Embodiment 3

[0055] This example is used to illustrate the inhibitory effect of the siRNA recombinant vector for silencing human CDT1 gene provided by the present invention on the expression of CDT1 gene in human hepatocyte HL-7702.

[0056] 1. Cell culture

[0057] The normal human liver cells HL-7702 in good condition were inoculated in 6-well cell culture plates in RPMI1640 medium containing 20% ​​(v / v) calf serum, 100 U / ml penicillin and 100 mg / L streptomycin ( USA, Invitrogen Company), at 37°C, 5% (v / v) CO 2 cultured under the same conditions until the cell confluency reached about 80%.

[0058] At the same time, the cultured cells were divided into 4 groups, namely 3 experimental groups and 1 control group.

[0059] 2. Gene transfection

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a siRNA (small interfering RNA) of a CDT1 gene of a silent person. The siRNA has any sequence of SEQ ID NO.1, SEQ ID NO.2 or SEQ ID NO.3. The invention also provides a recombinant vector containing the siRNA of the CDT1 gene of the silent person, and the application of the siRNA containing the CDT1 gene of the silent person and the recombinant vector. The siRNA of the CDT1 gene of the silent person and the recombinant vector, provided by the invention, can provide an effective technical tool for researching the functions of human CDT1 genes.

Description

technical field [0001] The invention belongs to the technical fields of molecular biology and biopharmaceuticals, and specifically relates to siRNA for silencing human CDT1 gene, recombinant vector and application. Background technique [0002] RNAi is a post-transcriptional gene silencing mechanism that reduces the expression of target genes by causing homologous mRNA degradation by double-stranded RNA (dsRNA). This phenomenon is conserved and widespread during evolution. At present, RNAi technology has entered many fields of biological science research and has become a major biological research tool. It provides a new research method for the analysis of gene function, signal transduction pathway and gene therapy. It won the Nobel Prize in 2006. prize. RNAi has the following characteristics and advantages: 1. The specificity of action, it only produces inhibitory effect on its homologous mRNA, and base mismatch will greatly reduce the inhibitory efficiency; 2. RNAi is high...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113C12N15/867C12N15/63C12N5/10
Inventor 左雅慧党旭红刘建功张慧芳段志凯李幼忱王超刘红艳杨彪
Owner CHINA INST FOR RADIATION PROTECTION